Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

This publication has 14 references indexed in Scilit:

• Paclitaxel (Taxol)
  New England Journal of Medicine, 1995
• Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.
  Journal of Clinical Oncology, 1993
• Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• VP-16 + adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A southwest oncology group study
  Medical and Pediatric Oncology, 1988
• The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.
  Journal of Clinical Oncology, 1987
• Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial
  European Journal of Cancer and Clinical Oncology, 1986
• Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized study
  Published by Elsevier ,1980
• Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustard
  Cancer, 1976
• Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination
  British Journal of Cancer, 1975